• NEBANNER

China wholesale Treatment Of Water - 2′-hydroxy-3′-nitro-3-biphenylcarboxylic acid – JIN DUN

China wholesale Treatment Of Water - 2′-hydroxy-3′-nitro-3-biphenylcarboxylic acid – JIN DUN

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

abide by the contract", conforms to the market requirement, joins during the market competition by its superior quality also as provides extra comprehensive and exceptional service for consumers to let them turn into significant winner. The pursue of the business, is definitely the clients' gratification for Tramadol Analgesic, Under Counter Water Filter System, Cyanide Treatment In Wastewater, We sincerely welcome overseas customers to consult for the long-term cooperation and the mutual development.We strongly believe that we can do better and better.
China wholesale Treatment Of Water - 2′-hydroxy-3′-nitro-3-biphenylcarboxylic acid – JIN DUN Detail:

2′-hydroxy-3′-nitro-3-biphenylcarboxylic acid is used as the intermediate of Eltrombopag .
Eltrombopag, developed by GlaxoSmithKline (GSK) in the UK and later jointly developed with Novartis in Switzerland, is the first and only approved small molecule non peptide TPO receptor agonist in the world. Eltrombopag was approved by the US FDA in 2008 for the treatment of idiopathic thrombocytopenic purpura (ITP), and in 2014 for the treatment of severe aplastic anemia (AA). It is also the first drug approved by the US FDA for the treatment of AA in recent 30 years.
In december2012, the US FDA approved Eltrombopag for the treatment of thrombocytopenia in patients with chronic hepatitis C (CHC), so that hepatitis C patients with poor prognosis due to low platelet count can start and maintain interferon based standard therapy for liver diseases. On february3,2014, GlaxoSmithKline announced that the FDA granted the breakthrough treatment drug qualification of Eltrombopag for the treatment of hemopenia in patients with severe chemicalbook aplastic anemia (SAA) who did not fully respond to immunotherapy. On August 24, 2015, the US FDA approved Eltrombopag for the treatment of thrombocytopenia in adults and children aged 1 year and over with chronic immune thrombocytopenia (ITP) who have insufficient response to corticosteroids, immunoglobulins or splenectomy. On january4,2018, Eltrombopag was approved to be listed in China for the treatment of primary immune thrombocytopenia (ITP).


Product detail pictures:

China wholesale Treatment Of Water - 2′-hydroxy-3′-nitro-3-biphenylcarboxylic acid – JIN DUN detail pictures


Related Product Guide:

All we do is always involved with our tenet " Consumer initial, Trust first, devoting within the food stuff packaging and environmental defense for China wholesale Treatment Of Water - 2′-hydroxy-3′-nitro-3-biphenylcarboxylic acid – JIN DUN , The product will supply to all over the world, such as: Iran, Ghana, Honduras, They're durable modeling and promoting well all over the world. Under no circumstances disappearing key functions in a brief time, it's a must for yourself personally of fantastic quality. Guided by the principle of Prudence, Efficiency, Union and Innovation. the business make an awesome efforts to expand its international trade, raise its enterprise. rofit and improve its export scale. We have been confident that we will have a vibrant prospect and to be distributed all over the world in the years to come.
  • We have been engaged in this industry for many years, we appreciate the work attitude and production capacity of the company, this is a reputable and professional manufacturer.
    5 Stars By Elsie from Colombia - 2018.10.31 10:02
    The manufacturer gave us a big discount under the premise of ensuring the quality of products, thank you very much, we will select this company again.
    5 Stars By Gary from Morocco - 2018.06.30 17:29
    Write your message here and send it to us